Journal
PLACENTA
Volume 107, Issue -, Pages 51-58Publisher
W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2021.02.021
Keywords
Metformin; Pregnancy; Placental-mediated disease; Pre-eclampsia; Growth restriction
Ask authors/readers for more resources
The study found that metformin may regulate multiple biomarkers implicated in the pathogenesis of PMD by reducing levels of inflammatory cytokines, suppressing the release of angiogenic factors, and increasing levels of certain proteins. These findings suggest the exciting potential for metformin as a therapeutic and preventative agent in the treatment of PMD, which warrants further investigation.
Metformin reduces the incidence of placental-mediated disease (PMD) in pregnancies with and without diabetes, but the mechanism through which it exerts these effects is not yet fully understood. We performed a systematic review and meta-analysis to examine the effect of metformin on biomarkers implicated in the pathogenesis of PMD. We searched Medline, Embase and the Cochrane Library for studies of metformin and biomarkers of PMD in pregnancy. Meta-analysis was undertaken where comparable data were obtained from two or more studies. 12 studies were included in the final review. Meta-analysis of 2 studies including 323 pregnant women showed significantly reduced CRP levels following treatment with metformin compared to placebo [mean difference = -1.72, 95% CI (-2.97; -0.48); p = 0.007]. Metformin exposure was also associated with decreased levels of the inflammatory cytokines TNF alpha, IL-1a, IL-1b and IL-6 in serum, placenta and omental tissue taken from pregnant women. Metformin significantly decreased the release of anti-angiogenic factors sElt-1 and sEng from ex-vivo placental and umbilical vein tissue, and increased maternal serum levels of non-phosphorylated IGFBP-1. Overall, our findings show that metformin mediates several molecular pathways implicated in the pathogenesis of pre-eclampsia and intrauterine growth retardation. Metformin therefore has exciting potential as a therapeutic, as well as preventative, agent in the treatment of PMD, which warrants further investigation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available